Development of COVID-19 antiviral coatings for N95 respirators

开发用于 N95 呼吸器的 COVID-19 抗病毒涂层

• 批准号: 554383-2020
• 负责人: Musselman, Kevin
• 金额: $ 3.64万
• 依托单位: University of Waterloo
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=705424
• 关键词: Development; COVID; 19; antiviral; coatings

During the outbreak of COVID-19, personal protective equipment (PPE) has played a critical role as the first line of defense between the virus and people, particularly healthcare workers. This equipment, however, is not typically treated to have antiviral properties. Since the virus is viable in aerosols and on surfaces for days, contaminated PPE has become another potential source of virus infection, posing a risk to healthcare workers and others handling the waste. In this project, antiviral coatings that are effective for COVID-19 will be developed. This will include studies on virus viability and altered protein synthesis, after exposure to different coating materials. In collaboration with Eclipse Automation, manufacturing processes will be developed to deposit these antiviral coatings on the fabrics that are employed as the outer layer on N95 respirators. The developed technology will be transferred to industry to provide enhanced PPE for Canadians.

在COVID-19爆发期间，个人防护装备（PPE）发挥了关键作用， 这是病毒与人之间的第一道防线，特别是医护人员。这个设备， 然而，通常不进行处理以具有抗病毒特性。由于病毒在气溶胶和 受污染的个人防护装备已成为另一个潜在的病毒感染源， 对医疗工作者和其他处理废物的人造成风险。在该项目中，将开发对COVID-19有效的抗病毒涂层。这将包括在暴露于不同的包被材料后对病毒活力和改变的蛋白质合成的研究。与Eclipse Automation合作，将开发制造工艺，以将这些抗病毒涂层存款在织物上，用作N95灭菌器的外层。开发的技术将转移到工业界，为加拿大人提供更好的个人防护设备。